Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
Huang RY, Unadkat P, Bi WL, George E, Preusser M, McCracken JD, Keen JR, Read WL, Olson JJ, Seystahl K, Le Rhun E, Roelcke U, Koeppen S, Furtner J, Weller M, Raizer JJ, Schiff D, Wen PY. Huang RY, et al. Among authors: wen py. Neuro Oncol. 2019 Feb 14;21(2):234-241. doi: 10.1093/neuonc/noy126. Neuro Oncol. 2019. PMID: 30085283 Free PMC article.
Uncommon brain tumors.
Schiff D, Wen PY. Schiff D, et al. Among authors: wen py. Neurol Clin. 1995 Nov;13(4):953-74. Neurol Clin. 1995. PMID: 8584006 Review.
Neurologic emergencies in cancer patients.
Schiff D, Batchelor T, Wen PY. Schiff D, et al. Among authors: wen py. Neurol Clin. 1998 May;16(2):449-83. doi: 10.1016/s0733-8619(05)70072-4. Neurol Clin. 1998. PMID: 9537970 Review.
Medical management of patients with brain tumors.
Wen PY, Schiff D, Kesari S, Drappatz J, Gigas DC, Doherty L. Wen PY, et al. J Neurooncol. 2006 Dec;80(3):313-32. doi: 10.1007/s11060-006-9193-2. Epub 2006 Jun 29. J Neurooncol. 2006. PMID: 16807780 Review.
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD. Wen PY, et al. Clin Cancer Res. 2006 Aug 15;12(16):4899-907. doi: 10.1158/1078-0432.CCR-06-0773. Clin Cancer Res. 2006. PMID: 16914578 Clinical Trial.
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
Groves MD, Puduvalli VK, Chang SM, Conrad CA, Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen PY, Greenberg H, Abrey LE, DeAngelis LM, Hess KR, Lamborn KR, Prados MD, Yung WK. Groves MD, et al. Among authors: wen py. J Neurooncol. 2007 Feb;81(3):271-7. doi: 10.1007/s11060-006-9225-y. Epub 2006 Sep 22. J Neurooncol. 2007. PMID: 17031561 Clinical Trial.
634 results